Jupiter Life Line Hospitals Ltd (NSE: JLHL) and Paras Healthcare Ltd (NSE: PARASHLTH) are both listed in the Hospitals and Healthcare Centers industry. Jupiter Life Line Hospitals has a market capitalisation of ₹8,642 Cr and Paras Healthcare ₹7,999 Cr, as of 9 Nov 2026. Their P/E ratios are 44.5 and 170.3 respectively.
| Metric | Jupiter Life Line Hospitals | Paras Healthcare |
|---|---|---|
| NSE Symbol | JLHL | PARASHLTH |
| BSE Code | 543980 | 545005 |
| Share Price | ₹293.00 | ₹752.00 |
| Market Cap | ₹8,642 Cr | ₹7,999 Cr |
| P/E Ratio | 44.5 | 170.3 |
| Return on Equity | 13.73% | — |
| Return on Assets | 7.44% | 18.20% |
| Dividend Yield | 0.08% | — |
| Beta (1Y) | 0.1 | — |
| 1-Year Price Change | -6.6% | — |
| 3-Month Price Change | -8.4% | — |
| 52-Week Range | ₹233.40 – ₹340.00 | ₹706.00 – ₹794.40 |
| Latest Quarter | Q2 FY27 | Q2 FY27 |
| Quarterly Revenue | ₹457 Cr | ₹511 Cr |
| Quarterly Net Profit | ₹56 Cr | ₹40 Cr |
| Net Margin | 12.3% | 7.9% |
| EPS (Basic, Quarter) | ₹1.72 | ₹4.00 |
| Results Basis | consolidated | consolidated |
| Headquarters | Mumbai, Maharashtra | Gurugram, Haryana |
The figures sit side by side and are not ranked. Quarterly figures are in ₹ crore, parsed from each company's exchange filing (XBRL); the two companies' latest quarters can differ.
Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT, HPB and surgical gastroenterology, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, neurosurgery, nutrition and dietetics, Obs and gynecology, on…
Paras Healthcare Limited provides tertiary and quaternary healthcare services. The company provides cardiac sciences, neurosciences, oncology sciences, gastro sciences, orthopedics and sports injury, and renal sciences services. It offers services, such as cardio thoracic vascular surgery and cardiology; medical, radiation, surgical, and hemato oncology, as well as nuclear medicine and bone marrow transplant; and neuroscience, neuro intervention, neurology, and spine surgery. The company also provides gastrointestinal surgery, gastroenterology, and liver transplant; nephrology, urology, and ki…
Jupiter Life Line Hospitals has a market capitalisation of ₹8,642 Cr, against ₹7,999 Cr for Paras Healthcare as of 9 Nov 2026, so the two are about the same size by market cap.
Jupiter Life Line Hospitals has a P/E of 44.5 and Paras Healthcare a P/E of 170.3 as of 9 Nov 2026.
Jupiter Life Line Hospitals reported revenue of ₹457 Cr and net profit of ₹56 Cr for Q2 FY27. Paras Healthcare reported revenue of ₹511 Cr and net profit of ₹40 Cr for Q2 FY27. Figures are parsed from each company's exchange filing.
Both are classified under Health Care Providers and Services > Health Care Facilities > Hospitals and Healthcare Centers on FinBizNet.
No. The page lays the two companies' published figures side by side and draws no conclusion from them. It is descriptive market data, not investment advice.
Data as of 9 Nov 2026. Descriptive market data only — not investment advice.